---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-22-000265"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2022-02-11T23:59:59+00:00"
generated_at: "2026-06-27T08:50:00.857491+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Arcturus CMO Steve Hughes steps down; Kelly Lindert named Chief Development Officer, Vaccines

## Summary
- Dr. Steve Hughes resigns as CMO effective Feb 14, 2022, to become Strategic Clinical Advisor.
- Dr. Kelly Lindert, formerly SVP and Head of Vaccines, appointed Chief Development Officer, Vaccines.
- Hughes will continue supporting Arcturus programs in an advisory capacity.

## SEC filing metadata
- accession: 0001193805-22-000265
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2022-02-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000265/0001193805-22-000265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000265/e621318_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-22-000265
- JSON: https://secwatch.observer/filing/0001193805-22-000265.json
- Plain text: https://secwatch.observer/filing/0001193805-22-000265.txt

## Key facts
- Executive change
  Steve Hughes departed as Chief Medical Officer at Arcturus Therapeutics Holdings Inc..
  - Action: stepped down
  - Role: Chief Medical Officer
  source text: Effective February 14, 2022, Dr. Steve Hughes will step down from his position as Chief Medical Officer of Arcturus Therapeutics Holdings Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000265/0001193805-22-000265-index.htm
- Executive change
  Kelly Lindert was appointed as Chief Development Officer, Vaccines at Arcturus Therapeutics Holdings Inc..
  - Action: appointed
  - Role: Chief Development Officer, Vaccines
  source text: Dr. Kelly Lindert, the Company’s Senior Vice President and Head of Vaccines, will take on the role of Chief Development Officer, Vaccines, for the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000265/0001193805-22-000265-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.